SGMO Overview
Upcoming Projects (SGMO)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (SGMO)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (SGMO)
-
Exploring the recent hemophilia A - SB-525 gene therapy data from Sangamo
Tickers: SGMO, PFE
Execute By: Aug 30, 2019 -
A discussion on lysosomal storage diseases and where Sangamo (SGMO) and Abeona's genetic treatments fit in.
Tickers: SGMO, ABEO
Execute By: Jul 06, 2017
Upcoming & Overdue Catalysts (SGMO)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (SGMO)
-
Sangamo's (SGMO) ST-920 in Fabry Disease Initial Phase 1/2 data expected Q4 2021
Ticker: SGMO
Occurred on: Nov 04, 2021 -
Phase 1/2 initial data of Sangamo's (SGMO) SB-525 in Hemophilia A due at ISTH
Ticker: SGMO
Occurred on: Jul 05, 2019 -
Sangamo Therapeutics (SGMO) to submit IND in 2018 for cDNA gene therapy, which is designed to treat Fabry disease
Ticker: SGMO
Occurred on: Feb 20, 2019 -
Initial Safety Data from CHAMPIONS Genome Editing Study for MPS II at WORLDSymposium
Ticker: SGMO
Occurred on: Feb 06, 2018 -
Sangamo Therapeutics (SMGO) earns FDA Fast Track Designation for SB-318 And SB-913 in treatment of Mucopolysaccharidosis (MPS) I and II
Ticker: SGMO
Occurred on: Jun 13, 2017 -
FDA Grants Rare Pediatric Disease Designation to Sangamo's (SGMO) SB-318 for Mucopolysaccharidosis Type I (MPS I)
Ticker: SGMO
Occurred on: Feb 27, 2017 -
FDA Designates Sangamo's (SGMO) SB-318 an Orphan Drug in Treatment of Mucopolysaccharidosis Type I (MPS I)
Ticker: SGMO
Occurred on: Jan 11, 2017 -
Sangamo BioSciences Announces New Gene Therapy Clinical Development Program for Treatment Of Hemophilia A
Ticker: SGMO
Occurred on: Jul 26, 2016 -
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Ticker: SGMO
Occurred on: Feb 08, 2016
Strategic Initiatives (SGMO)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
